These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31307045)

  • 1. Elevated TNIP3 mRNA Expression in TNF-α-Secreting Cells from Patients with Major Depressive Disorder.
    Huang KW; Wu MK; Hung YY
    Neuroimmunomodulation; 2019; 26(3):153-158. PubMed ID: 31307045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNIP2 mediates GRβ-promoted inflammation and is associated with severity of major depressive disorder.
    Chiang TI; Hung YY; Wu MK; Huang YL; Kang HY
    Brain Behav Immun; 2021 Jul; 95():454-461. PubMed ID: 33932528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
    Hung YY; Lin CC; Kang HY; Huang TL
    Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Histone Modification of TNFAIP3, TLR4, TNIP2, miR-146a, and miR-155 in Major Depressive Disorder.
    Tseng CC; Wang SC; Yang YC; Fu HC; Chou CK; Kang HY; Hung YY
    Mol Neurobiol; 2023 Aug; 60(8):4753-4760. PubMed ID: 37148522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants Improve Negative Regulation of Toll-Like Receptor Signaling in Monocytes from Patients with Major Depression.
    Hung YY
    Neuroimmunomodulation; 2018; 25(1):42-48. PubMed ID: 29898456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder.
    Hung YY; Huang KW; Kang HY; Huang GY; Huang TL
    Psychopharmacology (Berl); 2016 May; 233(9):1707-14. PubMed ID: 26415953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFAIP3 mRNA Level Is Associated with Psychological Anxiety in Major Depressive Disorder.
    Chen RA; Huang TL; Huang KW; Hung YY
    Neuroimmunomodulation; 2017; 24(4-5):271-275. PubMed ID: 29486471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIGIRR and TNFAIP3 Are Differentially Expressed in Both PBMC and TNF-α Secreting Cells of Patients With Major Depressive Disorder.
    Lin CC; Huang TL
    Front Psychiatry; 2021; 12():698257. PubMed ID: 34393859
    [No Abstract]   [Full Text] [Related]  

  • 9. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 Correlates with Severity of Depression in Patients with Major Depressive Disorder and Is Ameliorated after Antidepressant Treatment.
    Hung YY; Wu MK; Tsai MC; Huang YL; Kang HY
    Cells; 2019 Jun; 8(7):. PubMed ID: 31252530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression.
    Zou W; Feng R; Yang Y
    PLoS One; 2018; 13(6):e0197267. PubMed ID: 29856741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression.
    Urbano PCM; Aguirre-Gamboa R; Ashikov A; van Heeswijk B; Krippner-Heidenreich A; Tijssen H; Li Y; Azevedo VF; Smits LJT; Hoentjen F; Joosten I; Koenen HJPM
    J Allergy Clin Immunol; 2018 Aug; 142(2):517-529. PubMed ID: 29248493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression.
    Fitzgerald P; O'Brien SM; Scully P; Rijkers K; Scott LV; Dinan TG
    Psychol Med; 2006 Jan; 36(1):37-43. PubMed ID: 16255837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
    Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder.
    Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
    Int Immunopharmacol; 2023 May; 118():110108. PubMed ID: 37004349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder.
    Gao W; Gao Y; Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
    BMC Psychiatry; 2024 Jun; 24(1):449. PubMed ID: 38877455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between major depressive disorder and pro-inflammatory cytokines and acute phase proteins among HIV-1 positive patients in Uganda.
    Musinguzi K; Obuku A; Nakasujja N; Birabwa H; Nakku J; Levin J; Kinyanda E
    BMC Immunol; 2018 Jan; 19(1):1. PubMed ID: 29298663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder.
    Lee H; Song M; Lee J; Kim JB; Lee MS
    J Affect Disord; 2020 Apr; 266():57-62. PubMed ID: 32056928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Sertraline on Serum Cytokine Levels in Adolescents With First-Episode Major Depressive Disorder].
    Xiang JJ; Hong S; Ran LY; Zeng Q; Kong YT; Zhang CY; Liao J; Kuang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):310-315. PubMed ID: 36949691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between inflammatory cytokines and symptoms of major depressive disorder in adults.
    Min X; Wang G; Cui Y; Meng P; Hu X; Liu S; Wang Y
    Front Immunol; 2023; 14():1110775. PubMed ID: 36860860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials?
    Zimmerman M; Walsh E; Chelminski I; Dalrymple K
    J Affect Disord; 2017 Mar; 211():60-64. PubMed ID: 28088058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.